[ March 2007 ]
Sanofi-aventis and DNDi launched ASAQ, the new fixed-dose combination of artesunate (AS) and amodiaquine (AQ), which is now available in 21 countries throughout sub-Saharan Africa (June 08). ASAQ, the first drug developed by DNDi, is an innovative product to treat malaria that is adapted to the needs of patients of all ages, simple to use, accessible as a non patented drug, and available at an affordable price.
[ March 2007 ]
DNDi participated in two symposiums at the ASTMH in Atlanta.
[ September 2006 ]
Over 200 African scientists from 34 countries met in Nairobi, Kenya, 19-23 September at an international conference organised by the Drugs for Neglected Diseases initiative (DNDi), to explore developing greater regional research partnerships to combat the most neglected diseases, such as sleeping sickness, kala azar and malaria.
6-11 August 2006 ]
11th International Congress of Parasitology.
[17 June 2006]
[8 February 2006
European Parliament, Brussels, Belgium
[12-16 December 2005
Washington DC, USA
The 54th annual American Society of Tropical Medicine and Hygiene (ASTMH) Conference.
[11 September 2005 to 15 September 2005]
[05 April 2005]
Rio de Janeiro , Brazil
[18 January 2005
[07 November 2004 to 11 November 2004
Miami, United States
The 53rd annual meeting of the American Society of Tropical Medicine and Hygiene.
[7-8 October 2004]
The 25th African Health Sciences Congress.
[27 July 2004]
Workshop organized to discuss the collaboration of international initiatives involved in interventions for Poverty Related Diseases.
[09-10 February 2004]
Kuala Lumpur, Malaysia
[6-7 February 2004
7-9 May 2003
DNDi regional office conference.
[13-14 March 2003
Institut Pasteur, Paris